Lymphatic malformations

Lymphatic malformations (LMs) are congenital, benign slow-flow vascular malformations of the lymphatic system characterized by abnormally dilated lymphatic vessels that do not connect properly to the normal lymphatic circulation.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 3 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Lymphatic malformations (LMs) are congenital, benign slow-flow vascular malformations of the lymphatic system characterized by abnormally dilated lymphatic vessels that do not connect properly to the normal lymphatic circulation. These malformations represent developmental anomalies that occur during embryonic lymphatic system formation and are primarily caused by somatic activating mutations in the PIK3CA gene, found in approximately 75-80% of cases.

The umberella term "lymphatic malformation" has replaced older terminology including "lymphangioma," "cystic hygroma," and "lymphangioma circumscriptum." This is because the suffix -ioma imply a relationship to cancer, but these malformations are not cancerous.

Classification

According to the International Society for the Study of Vascular Anomalies (ISSVA), lymphatic malformations are classified as slow-flow vascular malformations (distinguished from vascular tumors which have proliferative endothelial cells) and are divided into three main categories:

Epidemiology

The overall incidence of lymphatic malformations ranges from 1 in 6000 to 1 in 16,000, with no predilection for sex or race. However, precise epidemiological data is difficult to establish due to variations in diagnosis, classification systems, and reporting practices across different healthcare systems.

Based on these incidence rates, lymphatic malformations are classified as rare diseases. While lymphatic malformations can become evident at any age, most are identified at birth or in early childhood, though some may not be noticed until the teenage years or early adulthood if small or located inside the body.

Approximately 75% occur in the lymphatic-rich head and neck region, though they can affect any part of the body including the axilla, mediastinum, buttock, pelvis, and other locations.

Clinical Presentation

]]Lymphatic malformations typically present as soft, compressible masses that can vary significantly in size and location. The clinical presentation depends on the type and location: Microcystic lymphatic malformations (formerly lymphangioma circumscriptum): Appear as clusters of small, translucent vesicles on the skin surface Range in color from pink to dark red May leak clear lymphatic fluid or occasionally bleed when ruptured Macrocystic lymphatic malformations (formerly cystic hygroma): Present as larger, deeper masses with a soft, doughy consistency Commonly occur in the neck (75%), axilla, or groin Can cause compression symptoms if large May fluctuate in size Mixed malformations: Display characteristics of both microcystic and macrocystic types Can be more complex and challenging to treat

Treatment

Treatment approach depends on the size, location, severity of symptoms, and impact on quality of life and function. The goal is not merely cosmetic improvement, but comprehensive management of symptoms, prevention of complications, and optimization of quality of life. Treatment decisions should involve multidisciplinary teams familiar with vascular anomalies, as these conditions are often poorly understood by general medical practitioners.

History

The understanding and classification of lymphatic malformations has evolved significantly: 1828: Redenbacher first described lymphangioma lesions. 1843: Wernher described the condition in his 1843 publication, Die angeborenen Kysten-hygrome und die ihnen verwandten Geschwülste (Congenital cystic hygromas and related tumors).

1965: Bill and Summer proposed that cystic hygromas and lymphangiomas represent variations of a single entity. 1976: Whimster studied the pathogenesis of lymphangioma circumscriptum, providing insights into the developmental basis. 2014-2015: Discovery of PIK3CA mutations as the primary cause of lymphatic malformations, revolutionizing understanding of pathogenesis.

2018: ISSVA classification update standardizing terminology to "lymphatic malformation".

Text derived from https://en.wikipedia.org/w/index.php?oldid=1345366357 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

5 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.